QuiVad

Home / Netherlands / Aperam S.A.

Aperam S.A.

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 11.27% on April 22, 2015. The shaded band is the year shown above.

November 1, 2012 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

711 disclosures on record for this share.
DateFund% of capitalEnd of publication
December 5, 2024Millennium Capital Partners LLP1.10%still open
November 26, 2024Millennium International Management LP1.00%still open
November 25, 2024Millennium Capital Partners LLP1.01%still open
November 25, 2024Millennium International Management LP0.97%still open
November 25, 2024Qube Research & Technologies Ltd.0.42%still open
November 21, 2024Millennium Capital Partners LLP0.97%still open
November 21, 2024Millennium International Management LP0.80%still open
November 20, 2024Millennium International Management LP0.72%still open
November 20, 2024Qube Research & Technologies Ltd.0.59%still open
November 19, 2024Millennium Capital Partners LLP0.82%still open
November 18, 2024Millennium Capital Partners LLP0.76%still open
November 18, 2024Millennium International Management LP0.61%still open
November 18, 2024Qube Research & Technologies Ltd.0.60%still open
November 13, 2024Qube Research & Technologies Ltd.0.54%still open
November 13, 2024Millennium International Management LP0.51%still open
November 12, 2024Millennium Capital Partners LLP0.60%still open
November 11, 2024JPMorgan Asset Management (UK) Ltd.0.42%still open
November 5, 2024Qube Research & Technologies Ltd.0.48%still open
October 30, 2024Millennium Capital Partners LLP0.56%still open
October 29, 2024Millennium Capital Partners LLP0.60%still open
October 17, 2024Qube Research & Technologies Ltd.0.52%still open
October 10, 2024Qube Research & Technologies Ltd.0.49%still open
October 1, 2024Millennium Capital Partners LLP0.58%still open
September 30, 2024Millennium Capital Partners LLP0.60%still open
September 27, 2024Qube Research & Technologies Ltd.0.51%still open
September 27, 2024Millennium Capital Partners LLP0.49%still open
September 26, 2024Millennium Capital Partners LLP0.51%still open
September 24, 2024Qube Research & Technologies Ltd.0.47%still open
August 22, 2024Qube Research & Technologies Ltd.0.50%still open
May 29, 2024JPMorgan Asset Management (UK) Ltd.0.72%still open
May 16, 2024JPMorgan Asset Management (UK) Ltd.0.67%still open
April 2, 2024Qube Research & Technologies Ltd.0.46%still open
March 21, 2024Qube Research & Technologies Ltd.0.51%still open
February 7, 2024ExodusPoint Capital Management, LP0.46%still open
January 15, 2024ExodusPoint Capital Management, LP0.50%still open
January 10, 2024ExodusPoint Capital Management, LP0.47%still open
January 8, 2024ExodusPoint Capital Management, LP0.50%still open
January 5, 2024ExodusPoint Capital Management, LP0.49%still open
January 2, 2024Qube Research & Technologies Ltd.0.49%still open
December 13, 2023ExodusPoint Capital Management, LP0.57%still open
November 30, 2023Qube Research & Technologies Ltd.0.52%still open
November 3, 2023ExodusPoint Capital Management, LP0.61%still open
October 26, 2023ExodusPoint Capital Management, LP0.50%still open
September 26, 2023Pantechnicon Advisors LLP0.39%still open
September 1, 2023Pantechnicon Advisors LLP0.63%still open
August 24, 2023ExodusPoint Capital Management, LP0.49%still open
August 17, 2023Pantechnicon Advisors LLP0.59%still open
August 1, 2023Pantechnicon Advisors LLP0.60%still open
July 27, 2023Pantechnicon Advisors LLP0.59%still open
July 24, 2023Pantechnicon Advisors LLP0.60%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Aperam S.A., source AFM, data as at March 11, 2026, https://www.quivad.com/action/aperam-s-a?page=2